Envisioning Cannabinoid CB1 Receptor Biased Signaling as a Therapeutic Target for Schizophrenia. [PDF]
Ku SH +4 more
europepmc +1 more source
Evolving prokinetic therapy: New targets and therapeutic opportunities in gastrointestinal motility disorders. [PDF]
Goyal O +10 more
europepmc +1 more source
CB1 Receptor Allosteric Modulators Display Both Agonist and Signaling Pathway Specificity
G. Baillie +10 more
semanticscholar +1 more source
Receptor-Selective Modulation of Cannabinoid Signaling by Cardamonin: Integrating Molecular Dynamics, Free Energy Calculations, and Behavioral Validation. [PDF]
Khalid MH +7 more
europepmc +1 more source
Dual Role of the Spinal Endocannabinoid System in Response to Noxious Stimuli: Antinociceptive Pathways and Neuropathic Pain Mechanisms. [PDF]
Saldaña R +5 more
europepmc +1 more source
Modulation of monoaminergic neurotransmission in substance use disorders: a neuropharmacological perspective focusing on plant-derived metabolites. [PDF]
Sivamaruthi BS +3 more
europepmc +1 more source
Therapeutic Potential of Cannabinoid Receptors Type 1 and 2-Novel Insights for Enhancing the Chance of Clinical Success. [PDF]
Grether U.
europepmc +1 more source
Postnatal development of cannabinoid receptor type 1 expression in rodent somatosensory cortex.
Suvarna Deshmukh +6 more
semanticscholar +1 more source
Irritable Bowel Syndrome Clinical Care Gaps and the Potential of Future Therapeutics Based on Peripheral Visceral Afferent Modulation. [PDF]
Camilleri M.
europepmc +1 more source
Exploring cannabinoid modulation on autophagy mechanisms in Alzheimer's disease: a review. [PDF]
Ntsapi C +4 more
europepmc +1 more source

